Compare Price To Sales Ratio Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Price To Sales Ratio Analysis
Select Fundamental
2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LUMO | 17.8646 | 2.5341 | 17.1075 | 56.5524 | 0.7409 | 3.198 | 9.3876 | 72.3298 | 5.2083 | 0.3911 | 1.4 K | 251 | 19.8486 | 12.6288 | 12.0 |
XCUR | 255 | 255 | 255 | 255 | 255 | 255 | 588 | 62.9231 | 6.2 K | 636 | 46.4547 | (185) | 0.9215 | 1.06 | 1.01 |
PTIX | 1.4 K | 1.4 K | 1.4 K | 0.2585 | 0.2585 | 0.2585 | 0.2585 | 0.2585 | 0.2585 | 0.2585 | 0.2585 | 0.2585 | 0.2585 | 0.3 | 0.28 |
PMVP | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ANEB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Lumos Pharma, Exicure, and Protagenic Therapeutics Price To Sales Ratio description
Price to Sales Ratio is figured by comparing entities stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on companies sales, a figure that is much harder to manipulate than other organizations multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Casinos Invested over 90 shares | ||
Macroaxis Index Invested few shares | ||
Warren Buffett Holdings Invested over 60 shares | ||
Hedge Favorites Invested over 100 shares | ||
Banking Invested over 20 shares | ||
Macroaxis Picks Invested over 40 shares | ||
Blockchain Invested few shares | ||
Investor Favorites Invested few shares | ||
Automobiles and Trucks Invested over 50 shares | ||
Manufacturing Invested over 30 shares | ||
Business Services Invested few shares | ||
Chemicals Invested over 30 shares | ||
Momentum Invested over 60 shares | ||
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |